Background and Objective: Nowadays, the presence of extended-spectrum β-lactamases (ESBLs) producing strains in Serratia genus causes the emergence of resistance to many antibiotics. So, the lack of proper diagnosis of ESBLs strains can lead to failure in the treatment. The objective of the present study was to investigate ESBLs production in Serratia strains isolated from the clinical blood samples in Shiraz, Iran. Materials and Methods: In this study, 39 Serratia strains isolated from the patients referred to Namazi Hospital, during a 2 year period were tested. The antimicrobial resistance of the isolates to 21 antibiotics was evaluated using Kirby-Bauer disk diffusion method. Combination disk method was used to determine the ESBL phenotype among the isolates. PCR was performed to investigate the presence of ESBL genes of SHV, OXA and TEM types.
INTRODUCTION
Extended spectrum β-lactamases (ESBLs) emerged among Enterobacteriaceae causes a major problem in the treatment of nosocomial infections, thanks to rendered resistance to oxyimino-cephalosporins (e.g. ceftazidime and cefepime) and monobactams (e.g. aztreonam) (1). ESBLs are plasmid-mediated enzymes, mostly found in Klebsiella pneumoniae and Escherichia coli, but also described in bacteria of Citrobacter, Enterobacter, Salmonella, Shigella, Proteus, Serratia, . Non-ESBL producing organisms can be changed to ESBL-producing organisms mostly through mutations in parent β-lactamases, particularly TEM-1, TEM-2 and SHV-1. There are various genes of ESBLs worldwide, with TEM, OXA, CTX-M and SHV as the most common ones. The SHV, TEM and CTX-M enzymes are of Ambler molecular class A and Bush group 2be, but OXA-type β-lactamase belongs to class D and group 2d (5). First reports on ESBL-producing organisms were published in Germany in 1983 (6). In the next decade, the majority of reports came from France, and then ESBL-producing organisms spread across the world (7) . In recent years, nosocomial infections caused by Serratia strains have become a growing concern. The ability of this opportunistic pathogen to acquire resistance to a broad spectrum of antibiotics has made the effective treatment more difficult. ESBL-producing enzymes rose up among Serratia genus and have increased multidrug resistance (8). Such β-lactamases are quickly transferable and have become a significant issue for human health conditions. The objectives of this study were to evaluate ESBL production and identify the types of such enzymes among Serratia strains, isolated from the blood samples of the patients in Shiraz Namazi Hospital, southern Iran.
MaTERIaLS aND METHODS
Serratia isolates. This study was conducted at Professor Alborzi Clinical Microbiology Research Center (PACMRC) in Namazi Hospital, Shiraz, Iran, on 39 Serratia strains. The strains were isolated from BACTEC bottles of blood samples of the patients referred to the lab during a period of 2 years from March 2010 to March 2012. All isolates were identified based on the biochemical-microbial tests and then speciated using diagnostic Microgene Bioproducts kit (GN-ID A Panel U.K).
Determination of antimicrobial resistance.
Antimicrobial resistance of the strains against 21 antibiotics was determined using standard KirbyBauer agar disk diffusion test, according to the CLSI protocol (Mast Co, U.K antimicrobial disk) (9 pCR amplification for the detection of ESBL genes. To amplify ESBL genes by PCR method, initially bacterial genome was extracted using boiling water bath for 10 minutes. Briefly, a bacterial suspension in 1.5 ml of distilled water was prepared and incubated at 95°C for 10 minutes. The sample was centrifuged at 8000 rpm for 15 min and then, the supernatant was used as DNA template. The presence of bla OXA-1 and bla SHV-1 within bacterial genome was investigated by multiplex PCR and for bla TEM gene by single PCR, using specific primers as shown in Table  1 . The cycling conditions for the detection of bla OXA and bla SHV were as follows: initial denaturation at 95°C for 15 min, 30 cycles of 94°C for 30 sec, 62°C for 90 sec and 72°C for 60 sec, and a final extention at 72°C for 10 min. The cycling conditions for the detection of bla TEM were initial denaturation at 94°C for 2 min, 30 cycles of 94°C for 15 sec, 55°C for 30 sec and 72°C for 45 sec, and a final elongation at 72°C for 10 min. Finally, the PCR products were detected by electrophoresis in a 2% agarose gel with 1X TAE buffer. Gel staining was then performed using ethidium bromide (0.5 µg/ml) and photographed under UV lamp (Gel documenter Uvitec, EEC, England).
Escherichia coli ATCC 25922 and previously characterized bla OXA and SHV positive Klebsiella pneumoniae, bla TEM -positive Salmonella enteritidis and Shigella sonnei strains were used as controls for ESBL analysis (3, 4).
Statistical analysis.
Phenotypic results and the data obtained from PCR assays were compared using SPSS statistical software, version 15 and Fisher's exact test. P-value equal or below 0.05 was considered as significant. and piperacillin/tazobactam (84.61%). The least susceptibility was observed for augmentin (7.69%) and tetracycline, ampicillin, cefuroxime (5.12%) but none of the isolates was susceptible to cephalexin.
Multidrug resistant strains.
The strains exhibiting resistance to more than 2 or 3 classes of antibiotics were considered as multidrug resistant (MDR) strains. The most frequent patterns of MDR among the 39 Serratia isolates were as cephalexin-chloramphenicolcefuroxime-ampicillin-tetracycline-augmentin and gentamicin-cephalexin-chloramphenicol-cefuroximeceftriaxone-cefotaxime-ampicillin-cefepime-ceftazidimetetracycline-amikacin-ticarcillin-ceftizoxime-tobramycinpiperacillin-augmentin-aztreonam with frequencies of 15.38% and 12.82%, respectively ( Table 2) .
Determination of ESBL phenotype. The results of combination disk assay showed that from all the strains, 69% (n = 27) were identified as positive ESBL phenotype. Moreover, it was also indicated that a high percentage of Serratia samples were fully resistant (R = 100%) to cefotaxime (CTX), but none was completely resistant to ceftazidime (CAZ).
Detection of bla OXa , bla SHV and bla TEM genes by PCR. Of 39 Serratia isolates, 10 samples (25.64%) demonstrated the presence of either OXA or SHV or both genes at the same time (Fig. 1a) . The OXA-1 gene was observed in 20.51% (n = 8) of the strains but SHV gene in 15.38% (n = 6). Moreover, bla TEM gene was not detected in any of the strains (Fig. 1b) .
Statistical analysis. To determine the relationship between the presence of ESBL gene and ESBL phenotype among the Serratia isolates, Fisher's exact test was performed and p-value was determined for each of the genes. P-value represents the reliability of the target gene for displaying the ESBL phenotype. The Statistical analysis showed that p-value for bla OXA and bla SHV genes were 0.042 and 0.151, respectively. However, due to the absence of bla TEM among the examined isolates, statistical analysis was not performed for this gene. The results were reliable for the bla OXA gene but it was not for SHV gene. However, it has been demonstrated that from 21 antibiotics tested, imipenem (5.12%) and meropenem (7.69) can be considered as the most effective drug for the treatment of infection caused by ESBL strains of Serratia, followed by fluoroquinolines (19). Among the strains under our study, 94.87% were MDR. This is probably due to the presence of mobile resistance elements carrying resistance genes to multiple antibiotics among the isolates. The PCR results obtained from this study showed that of the three genes under investigation for ESBL producing strains, bla OXA gene (20.51%) was the most frequent one among Serratia isolates. The frequency of bla SHV gene was 15.38%, but none of the isolates had bla TEM gene. Overall, the frequency of ESBL strains based on PCR results was 25.64% but 69.23% by phenotypic and responsible for 2% of nosocomial infections that are often caused by S. marcescens species, however, Serratia liquefaciens infections are rare and mostly due to poor hygiene. These organisms are involved in the development of some diseases such as meningitis, urinary tract infections, sepsis, bacteremia and endocarditis. Serratia strains are resistant to a range of antibiotics used to treat bacterial infections. ESBL genes are highly frequent in the majority of bacteria, especially Enterobacteriaceae family. Their presence among the bacteria makes them ESBL expressing organisms. Such bacteria become resistant to third and fourth generation cephalosporins and monobactams, in addition to the majority of antibiotics (14). ESBL producing organisms often colonized in the patients hospitalized for a long time, especially those who use urinary catheters or central venous lines. Different reports indicated the presence of ESBL producing strains among the Serratia genus (15,16). The treatment of diseases caused by ESBL organisms must be based on the results of new antibiogram tests but not empirical therapy because they have potential resistance to multiple antibiotics (17, 18) . In this study, phenotypic evaluation by combination disk method was indicative of a prevalence of 69% for ESBL producing strains in Serratia species. We diagnosed only two species of marcescens and liquefaciens among the Serratia isolates in our study. The prevalence of positive ESBL among these strains was 70.37% (n = 19) and 29.62% (n = 8), respectively. However, the rate of ESBL production in the Serratia 1a). The OXA-1 gene was observed in 20.51% (n=8) of the strains but SHV gene in 15.38% (n=6). Moreover, bla TEM gene was not detected in any of the strains (Fig 1b) . In conclusion, these data showed that carbapenems followed by ciprofloxacin and piperacillin/tazobactam are the most effective antibiotics against the Serratia strains isolated in our region, while cephalexin showed no effects on them. Moreover, according to the present phenotypic and genotypic data it seems that about 44% of the present ESBL producing strains carry β-lactamases genes other than the genes under investigation in this study. More genetic studies for detection of other ESBL genes are being pursued in our lab. Regarding the important role of Serratia as a causative agent in nosocomial infections and widespread presence of ESBL strains among them, developing and performing tests for the detection of ESBL producing Serratia strains as a routine test in clinical laboratories is recommended. 
DISCUSSION

pattern of MDR % of MDR
CFX-C-CXM-AP-T-AUG 15.38% GM-CFX-C-CXM-CRO-CTX-AP-CPM-CAZ-T-AK-TC-CZX-TN-PRL-AUG-ATM 12.82% GM-CFX-C-CXM-CRO-CTX-AP-CPM-CAZ-T-AK-TC-CZX-TN-PRL-PTZ-AUG-ATM 7.69%
